scholarly journals Percutaneous Renal Biopsy

10.5772/27715 ◽  
2012 ◽  
Author(s):  
Louis-Philippe Laurin ◽  
Alain Bonnardeaux ◽  
Michel Dube ◽  
Martine Leblanc
Keyword(s):  
Renal Biopsy ◽  
Percutaneous Renal Biopsy

The renal scan as an aid in percutaneous renal biopsy

JAMA ◽  
1966 ◽  
Vol 195 (11) ◽  
pp. 913-915 ◽  
Author(s):  
S. Baum
Keyword(s):  
Renal Biopsy ◽  
Percutaneous Renal Biopsy ◽  
Renal Scan

Yield and complications in percutaneous renal biopsy

1997 ◽  
Vol 38 (3) ◽  
pp. 431-436 ◽  
Author(s):  
R. S. Nyman ◽  
J. Cappelen-Smith ◽  
H. AL Suhaibani ◽  
O. Alfurayh ◽  
W. Shakweer ◽  
...  
Keyword(s):  
Renal Biopsy ◽  
Percutaneous Renal Biopsy

scholarly journals Safety of Renal Biopsy by Physicians with Short Nephrology Experience

Healthcare ◽  
2021 ◽  
Vol 9 (4) ◽  
pp. 474
Author(s):  
Kenta Torigoe ◽  
Kumiko Muta ◽  
Kiyokazu Tsuji ◽  
Ayuko Yamashita ◽  
Shinichi Abe ◽  
...  
Keyword(s):  
Renal Artery ◽  
Renal Biopsy ◽  
Renal Diseases ◽  
Complication Rates ◽  
Artery Embolization ◽  
Clinical Nephrology ◽  
Percutaneous Renal Biopsy ◽  
Artery Embolism ◽  
Renal Artery Embolization ◽  
Biopsy Complications

Percutaneous renal biopsy is an essential tool for diagnosing various renal diseases; however, little is known about whether renal biopsy performed by physicians with short nephrology experience is safe in Japan. This study included 238 patients who underwent percutaneous renal biopsy between April 2017 and September 2020. We retrospectively analyzed the frequency of post-renal biopsy complications (hemoglobin decrease of ≥10%, hypotension, blood transfusion, renal artery embolization, nephrectomy and death) and compared their incidence among physicians with varied experience in nephrology. After renal biopsy, a hemoglobin decrease of ≥10%, hypotension and transfusion occurred in 13.1%, 3.8% and 0.8% of patients, respectively. There were no cases of post-biopsy renal artery embolism, nephrectomy, or death. The composite complication rate was 16.0%. The incidence of post-biopsy complications was similar between physicians with ≥3 years and <3 years of clinical nephrology experience (12.5% vs. 16.8%, p = 0.64). Furthermore, the post-biopsy composite complication rates were similar between physicians with ≥6 months and <6 months of clinical nephrology experience (16.3% vs. 15.6%, p > 0.99). Under attending nephrologist supervision, a physician with short clinical nephrology experience can safely perform renal biopsy.

Antepartum Percutaneous Renal Biopsy

2008 ◽  
Vol 63 (1) ◽  
pp. 2-4
Author(s):  
D Wide-Swensson ◽  
H Strevens ◽  
J Willner
Keyword(s):  
Renal Biopsy ◽  
Percutaneous Renal Biopsy

PERCUTANEOUS RENAL BIOPSY IN CHILDREN

PEDIATRICS ◽  
1962 ◽  
Vol 30 (2) ◽  
pp. 287-296
Author(s):  
W. F. Dodge ◽  
C. W. Daeschner ◽  
J. C. Brennan ◽  
H. S. Rosenberg ◽  
L. B. Travis ◽  
...  
Keyword(s):  
Renal Disease ◽  
Renal Biopsy ◽  
Clinical Importance ◽  
Renal Diseases ◽  
Renal Lesion ◽  
Bleeding Tendency ◽  
Percutaneous Renal Biopsy ◽  
The One ◽  
Selection Of

Since 1951, when the percutaneous renal biopsy was introduced as an adjunctive method for study of patients with renal disease, reports of some 4,000 kidney biopsies have appeared in the literature. Only about 250 of these, however, have been performed in children. A biopsy specimen containing 5 to 10 glomeruli has been reported to be adequate for interpretation and to be representative of the total renal parenchyma in 84% of the cases with diffuse renal disease. Using a biopsy technique similar to that described by Kark, we have obtained an adequate specimen in 92% of 205 kidney biopsies performed in 168 children with diffuse renal diseases. Seven deaths have been previously reported in the literature. The circumstances surrounding the death of these seven patients and of the one death that occurred in our series are described. Perirenal hematoma has had a reported incidence of 0.4%. It has been our experience, as well as that of the other investigators, that if blood boss is replaced, the patient has an otherwise uneventful course and the mass subsequently disappears. Gross hematuria has had a reported incidence of 5.2%. Microscopic hematuria, lasting for 6 to 12 hours after biopsy, has been found to be the rule rather than the exception. The complications which have occurred have been associated with bleeding, and therefore a careful history concerning bleeding tendency and a study of the clotting mechanism is essential if the risk of needle renal biopsy is to be minimized. In addition to a bleeding tendency or defect in clotting mechanism, most investigators are agreed that the presence of only one kidney or an uncooperative patient are absolute contraindications to renal biopsy. The renal biopsy is primarily, at present, an additional and most useful investigative tool in the elucidation of the pathogenesis, natural history (by serial studies) and effectiveness of specific therapy upon the various renal diseases. It is of practical clinical importance in the selection of those patients with the nephrotic syndrome in whom glucocorticoid therapy is likely to be beneficial or the patient with anuria whose renal lesion is probably reversible with time; and, as a guide to the effectiveness of therapy in patients with pyelonephritis or lupus nephritis. It is not a technique that can be recommended for general or casual use. A classification of the pathohistobogic findings of diffuse glomerulonephritis, patterned after Ellis, is presented and discussed. This classification will be used in the description and discussion of various renal diseases and systemic diseases with associated nephritis in the three subsequent papers.

Sign in / Sign up

Export Citation Format

Share Document